The myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 production

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Tato, Cristina M ^a,b   Joyce Shaikh, Barbara ^a   Banerjee, Antara ^a   Chen, Yi ^a   Sathe, Manjiri ^a   Ewald, Sarah E ^b   Liu, Man Ru ^a   Gorman, Daniel ^a   McClanahan, Terrill K ^a   Phillips, Joseph H ^a   Heyworth, Paul G ^a   Cua, Daniel J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 27; INTERLEUKIN 27P28; INTERLEUKIN 27P70; PAIRED IMMUNOGLOBULIN LIKE RECEPTOR ALPHA; PAIRED IMMUNOGLOBULIN LIKE RECEPTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IL27 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN DERIVATIVE; PILRBETA PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CHRONIC ENCEPHALITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; ENCEPHALITIS; ENTERITIS; EXPERIMENTAL INFECTION; INFECTION RESISTANCE; INFLAMMATION; INFLAMMATORY INFILTRATE; INTERFERON PRODUCTION; INTESTINE NECROSIS; MACROPHAGE; MOUSE; NONHUMAN; SURVIVAL; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; C57BL MOUSE; CBA MOUSE; CELL CULTURE; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MICROGLIA; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TOXOPLASMA;

MUS; TOXOPLASMA GONDII;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; ENCEPHALITIS; FEMALE; GENE EXPRESSION; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKINS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICROGLIA; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84858960598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031680     Document Type: Article

References (48)

1. Turnbull IR, Colonna M, (2007) Activating and inhibitory functions of DAP12. Nat Rev Immunol 7: 155-161.
2. Mousseau DD, Banville D, L'Abbe D, Bouchard P, Shen SH, (2000) PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta. J Biol Chem 275: 4467-4474.
3. Fournier N, Chalus L, Durand I, Garcia E, Pin JJ, et al. (2000) FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells. J Immunol 165: 1197-1209.
4. Shiratori I, Ogasawara K, Saito T, Lanier LL, Arase H, (2004) Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J Exp Med 199: 525-533.
5. Tabata S, Kuroki K, Wang J, Kajikawa M, Shiratori I, et al. (2008) Biophysical characterization of O-glycosylated CD99 recognition by paired Ig-like type 2 receptors. J Biol Chem 283: 8893-8901.
6. Wang J, Shiratori I, Satoh T, Lanier LL, Arase H, (2008) An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR). J Immunol 180: 1686-1693.
7. Oh KI, Kim BK, Ban YL, Choi EY, Jung KC, et al. (2007) CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR zeta. Exp Mol Med 39: 176-184.
8. Bixel MG, Petri B, Khandoga AG, Khandoga A, Wolburg-Buchholz K, et al. (2007) A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo. Blood 109: 5327-5336.
9. Lou O, Alcaide P, Luscinskas FW, Muller WA, (2007) CD99 is a key mediator of the transendothelial migration of neutrophils. J Immunol 178: 1136-1143.
10. Dufour EM, Deroche A, Bae Y, Muller WA, (2008) CD99 is essential for leukocyte diapedesis in vivo. Cell Commun Adhes 15: 351-363.
11. Satoh T, Arase H, (2008) HSV-1 infection through inhibitory receptor, PILRalpha. Uirusu 58: 27-36.
12. Satoh T, Arii J, Suenaga T, Wang J, Kogure A, et al. (2008) PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132: 935-944.
13. Suzuki Y, Orellana MA, Schreiber RD, Remington JS, (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
14. Denkers EY, Gazzinelli RT, (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11: 569-588.
15. Yap GS, Sher A, (1999) Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201: 240-247.
16. Wilson EH, Hunter CA, (2004) The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis. Int J Parasitol 34: 543-548.
17. Liesenfeld O, (2002) Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185 (Suppl 1): S96-101.
18. Kasper L, Courret N, Darche S, Luangsay S, Mennechet F, et al. (2004) Toxoplasma gondii and mucosal immunity. Int J Parasitol 34: 401-409.
19. Banerjee A, Stevenaert F, Pande K, Haghjoo E, Antonenko S, et al. (2010) Modulation of paired immunoglobulin-like type 2 receptor signaling alters the host response to Staphylococcus aureus-induced pneumonia. Infect Immun 78: 1353-1363.
20. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
21. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
22. Chen ZY, He CY, Kay MA, (2005) Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther 16: 126-131.
23. Liu F, Song Y, Liu D, (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258-1266.
24. Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, et al. (1999) Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 162: 4511-4520.
25. Tait ED, Hunter CA, (2009) Advances in understanding immunity to Toxoplasma gondii. Mem Inst Oswaldo Cruz 104: 201-210.
26. Hunter CA, Abrams JS, Beaman MH, Remington JS, (1993) Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun 61: 4038-4044.
27. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA, (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74.
28. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, et al. (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8: 1363-1371.
29. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, et al. (2003) The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655.
30. Troy AE, Zaph C, Du Y, Taylor BC, Guild KJ, et al. (2009) IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis. J Immunol 183: 2037-2044.
31. Murugaiyan G, Mittal A, Lopez-Diego R, Maier LM, Anderson DE, et al. (2009) IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 183: 2435-2443.
32. Ilarregui JM, Croci DO, Bianco GA, Toscano MA, Salatino M, et al. (2009) Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 10: 981-991.
33. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, et al. (2000) IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol 164: 5375-5382.
34. Hamerman JA, Tchao NK, Lowell CA, Lanier LL, (2005) Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 6: 579-586.
35. Stumhofer JS, Hunter CA, (2008) Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 117: 123-130.
36. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, et al. (2006) IL-27 limits IL-2 production during Th1 differentiation. J Immunol 176: 237-247.
37. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, et al. (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7: 937-945.
38. Artis D, Villarino A, Silverman M, He W, Thornton EM, et al. (2004) The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J Immunol 173: 5626-5634.
39. Li J, Gran B, Zhang GX, Rostami A, Kamoun M, (2005) IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J Neurol Sci 232: 3-9.
40. Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, et al. (2005) Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res 1040: 202-207.
41. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, et al. (2007) Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 179: 3268-3275.
42. Liesenfeld O, Kang H, Park D, Nguyen TA, Parkhe CV, et al. (1999) TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol 21: 365-376.
43. Liesenfeld O, Kosek J, Remington JS, Suzuki Y, (1996) Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 184: 597-607.
44. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, et al. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
45. Niedbala W, Cai B, Wei X, Patakas A, Leung BP, et al. (2008) Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 67: 1474-1479.
46. Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, et al. (2007) Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8: 1372-1379.
47. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR, (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6: 169-175.
48. Diveu C, McGeachy MJ, Boniface K, Stumhofer JS, Sathe M, et al. (2009) IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 182: 5748-5756.